000			01791nas a22003615i 4500
001			1868-6966
003			DE-He213
005			20180511105611.0
007			cr nn 008mamaa
008			150723s||||||||au uu poo|||||| b|EN |d
022			_a1868-6966
024	7		_a10.1007/12645.1868-6966 _2doi
210	1	0	_aCancer Nano
245	1	0	_aCancer Nanotechnology _h[electronic resource] : _bBasic,Translational and Clinical Research / _cedited by Steven A. Curley, Frederick J. Currell.
264		1	_aVienna : _bSpringer Vienna : _bImprint: Springer.
300			_bonline resource.
520			_aCancer is a group of diseases driven by inherently nanostructural problems (e.g. DNA issues). As such, there are obvious benefits to treatments employing nanoscale structures and processes. Additionally, as nanotechnologies are developing at a rapid rate, it is likely that many new themes will develop within the area in the next few years. With this in mind, Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.
650		0	_aMaterials science.
650		0	_aCancer research.
650		0	_aBiochemistry.
650		0	_aBiomedical engineering.
650		0	_aNanotechnology.
650	1	4	_aMaterials Science.
650	2	4	_aNanotechnology.
650	2	4	_aCancer Research.
650	2	4	_aBiomedical Engineering.
650	2	4	_aBiochemistry, general.
700	1		_aCurley, Steven A. _eeditor.
700	1		_aCurrell, Frederick J. _eeditor.
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x1868-6958
856	4	0	_uhttp://dx.doi.org/10.1007/12645.1868-6966 _zOpen Access
999			_c189421 _d189421